BioCentury
ARTICLE | Company News

3SBio hematology, biosimilars news

October 8, 2012 7:00 AM UTC

3SBio's special committee of independent directors hired Jefferies as a financial advisor to review and evaluate a non-binding proposal to go private from CEO and Chairman Jing Lou and CPEChina Fund L.P. BofA Merrill Lynch is advising Lou and the fund. ...